These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24829597)

  • 1. Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity.
    Shin HY; Park HJ; Lee HE; Choi YC; Kim SM
    J Clin Neurol; 2014 Apr; 10(2):119-24. PubMed ID: 24829597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors.
    Lee HE; Kim YH; Kim SM; Shin HY
    J Clin Neurol; 2016 Oct; 12(4):482-488. PubMed ID: 27819419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.
    Modoni A; Mastrorosa A; Spagni G; Evoli A
    Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors.
    Chroni E; Punga AR
    J Neurol Sci; 2012 May; 316(1-2):150-7. PubMed ID: 22251934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis.
    Kim SW; Sunwoo MK; Kim SM; Shin HY; Sunwoo IN
    J Clin Neurol; 2017 Jul; 13(3):287-292. PubMed ID: 28516744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
    Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
    Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.
    He T; Chen K; Li Y; Luo Z; Luo M; Yang H
    Neuropsychiatr Dis Treat; 2024; 20():725-735. PubMed ID: 38566882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
    Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
    Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
    Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
    Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
    Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
    Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis].
    Konishi T; Kousaka M; Yamakawa K; Matsui M; Ohta K
    Rinsho Shinkeigaku; 2009 Oct; 49(10):660-3. PubMed ID: 19999149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
    Guptill JT; Sanders DB
    Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.
    Huijbers MG; Plomp JJ; van Es IE; Fillié-Grijpma YE; Kamar-Al Majidi S; Ulrichts P; de Haard H; Hofman E; van der Maarel SM; Verschuuren JJ
    Exp Neurol; 2019 Jul; 317():133-143. PubMed ID: 30851266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis.
    Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A
    Front Immunol; 2020; 11():613. PubMed ID: 32431692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.